Company Orchid Ventures, Inc. Canadian Securities Exchange
Equities
ORCD
CA68573L2066
Pharmaceuticals
Business Summary
Sales per Business
CAD in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
Vape
100.0
%
| 2 | 100.0 % | 5 | 100.0 % | +145.59% |
Sales per region
CAD in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
North Amercia
100.0
%
| 2 | 100.0 % | 5 | 100.0 % | +145.59% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Corey Mangold
CEO | Chief Executive Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Corey Mangold
CEO | Chief Executive Officer | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 52,437,123 | 41,481,192 ( 79.11 %) | 0 | 79.11 % |
Company contact information
Orchid Ventures, Inc.
27762 Antonio Parkway Suite L-1-631
92694, Ladera Ranch
+
http://orchidessentials.comSector
1st Jan change | Capi. | |
---|---|---|
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
-3.40% | 157B |